|
|
Dear Elysium Community,
Today Iām sharing our most significant announcement since Elysium launched in 2015:
The Elysium Longevity Institute (or TELI,
as itās known by our team).
TELI is a physician-led platform for personalized longevity medicineāa single, comprehensive program built on diagnostics and the latest science, designed to provide protocols that maximize healthspan.
Years in development,
The Institute will offer personalized prescriptions, injectables, peptides, and more in a first-of-its-kind programāguided by leading scientists and clinicians.
For over a decade, Elysium has led the way in commercializing longevity researchāfrom NAD+ to brain aging to biological age, and more. That work has made Elysium the worldās most clinically successful longevity company, while others have played catch up. Now, we see a new opportunity: As demand for serious longevity care accelerates, the category needs a higher standard. TELI is built to set it.
Ahead of our summer launch, we are opening the waitlist to the Elysium community
first. Claim your place and refer family and friends before we open it up to the public. When TELI launches, the first enrollment wave will be capped at 10,000 members, and
we expect it to fill quickly.
Join the waitlist now. Additional enrollment will follow as fast as responsibly possible.
Iām deeply optimistic about whatās aheadāand I hope you will join us as we change how longevity medicine is practiced.
|
|
|
|
In good health,
|
|
Eric Marcotulli
Elysium Health co-founder and CEO
|
|
|
|
|
|
|
|
|